바로가기 메뉴
본문내용 바로가기
하단내용 바로가기

메뉴보기

메뉴보기

발표연제 검색

연제번호 : P 1-149 북마크
제목 Osteoporosis in neurogenic heterotopic ossification patients
소속 Kwangju Christian Hospital, Department of Rehabilitation Medicine1
저자 Na Na Lim1*, Dong Youl Lee1, Ji Hong Cheon1, Geun Su Lee1, Youn Koung Cho 1†, Sung Hoon Lee1, Hyun Kyung Lee 1
Introduction
Heterotopic ossification (HO) is true bone in extraskeletal ectopic sites. For unknown reasons, pluripotent mesenchymal cells in soft tissues differentiate into osteoblasts and other cell lines involved with bone formation. HO usually presents a swallen, warm painful joint and make it difficult to maintain joint range of motion and its function. Furthermore, HO can also contribute to the development of pressure ulcers or causes compression of nerves and blood vessels and eventually patients need to have an operation.
Osteoporosis is another musculoskeletal problem for the patients with prolonged therapeutic bed rest, immobilization due to motor paralysis from injury of the central nervous system or peripheral nerves. Reduction of mechanical stress on bone inhibits osteoblast-mediated bone formation and accelerates osteoclast-mediated bone resorption.
We found out recently, a few HO patients had severe osteoporosis and gave pharmachological intervention such as zoledronic acid or ibandronic acid.

Cases
Following patients were tetraplegia and totally dependent on caregiver for transport. Both of them were taking dinol for their hip joint heterotopic ossification.

Case 1. A 24-year-old male patient who is tetraplegia d/t cervical level spinal cord injury, ASIA B(2016. 2. 24) and 18 months after the attack, his dual-energy X-ray absorptiometry(DEXA) results reveal that Z-score -3.4 in the Rt. femur trochanter.
Case 2. A 39-year-old female patient who is tetraplegia due to SAH at anterior communicating artery aneurysm rupture(2016. 6. 22) and 13 months after the attack, her DEXA results reveal that Z-score -5.7 in the left femur trochanter.

Conclusion
Age is a high risk factor for osteoporosis. In the newly updated osteoporosis guideline NOGG 2017, fracture probability should be assessed in postmenopausal women, and men age 50 years or more, who have risk factors for fracture, using FRAX. In individuals at intermediate risk, bone mineral density (BMD) measurement
should be performed using dual-energy X-ray absorptiometry and fracture probability re-estimated using FRAX. Those patients were far from younger than 50 years old, but have shown absolutely low bone mineral density.
Loss of bone and muscle develop in a vicious circle of immobilization caused by underlying diseases. Recommendation of osteoporosis screeing test such as DEXA for the young HO patients can be beneficial to predict the osteoporotic fracture risk and not to go through catastrophic experience as severe pain and disability to indifvisual sufferers.